Pierian Biosciences
Pierian Biosciences optimizes tech platforms for personalized cancer treatment strategies, enhancing patient life quality.
Founded
2008Pierian Biosciences optimizes tech platforms for personalized cancer treatment strategies, enhancing patient life quality.
Founded in Franklin, United States, Pierian Biosciences is a diagnostic development and laboratory service company committed to advancing personalized cancer treatment. Their core mission is to deliver innovative, treatment-directing assays and analytical approaches that guide personalized medicine and translational science. The company offers products such as CHEMOINTELâ„¢ and IMMUNOINTELâ„¢, which provide specific, actionable information on the most appropriate chemotherapeutic, biologic, and immunotherapeutic treatments for cancer patients.
Pierian Biosciences has a notable leadership team and board of directors who bring extensive expertise in oncology and diagnostics. The company has achieved significant milestones in optimizing their technology platforms to enhance the quality of life for cancer patients through personalized treatment strategies. Their impact is evident in the improved clinical outcomes and tailored therapeutic approaches they provide, positioning them as a pivotal player in the personalized medicine landscape.
Companies similar to Pierian Biosciences include Personalis, Empiri, Phigenix and Predictive Biosciences.
Pierian Biosciences was founded in 2008.
Pierian Biosciences' headquarters is located in Franklin, TN, US.
Pierian Biosciences' most recent funding round was for $18M (USD) in June 2013.
As of Jun 4, 2013, Pierian Biosciences has raised a total of $18M (USD).
Pierian Biosciences has 11 employees as of Feb 4, 2024.
Phigenix
phigenix.com
